Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Corrado Cilio

Professor

Default user image.

Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals

Author

  • Caroline Sandström
  • Natalia Novoradovskaya
  • Corrado Cilio
  • Eeva Piitulainen
  • Tomas Sveger
  • Sabina Janciauskiene

Summary, in English

Background: CD14, a receptor for lipopolysaccharides (LPS), is found in both a membrane-bound form (mCD14) and a soluble form (sCD14). It is suggested that sCD14 is mainly released from blood monocytes by serine protease-mediated shedding. Because alpha(1)-antitrypsin (AAT), an inhibitor of serine proteases, has been shown to regulate CD14 expression in human monocytes in vitro, we sought to investigate plasma levels of sCD14 and monocyte expression of mCD14 in subjects at age 30 years with normal MM and deficient PiZZ and PiSZ genotypes of AAT. Methods: Plasma levels of AAT and sCD14 were measured in 75 PiZZ and 34 PiSZ individuals with normal lung function identified from the Swedish neonatal AAT deficiency screening, and in 95 age matched PiMM controls. The mCD14 expression in monocytes from 9 PiZZ, 6 PiSZ and 11 PiMM subjects was analysed by FACS and Quantitative Real Time Reverse Transcription PCA. Results: As expected, plasma AAT concentrations were PiMM > PiSZ > PiZZ (p < 0.001). Plasma sCD14 levels were higher in PiZZ than in PiMM subjects (p < 0.01). The expression level of mCD14 was higher (1.89-fold) in monocytes isolated from PiZZ subjects compared to PiMM controls (p = 0.00189). Conclusion: This study is the first to show higher levels of plasma sCD14 and monocyte mCD14 expression in young, clinically healthy PiZZ AAT subjects.

Department/s

  • Chronic Inflammatory and Degenerative Diseases Research Unit
  • Diabetes - Immunovirology
  • Respiratory Medicine and Allergology
  • Preventive Paediatrics

Publishing year

2008

Language

English

Publication/Series

Respiratory Research

Volume

9

Issue

34

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Respiratory Medicine and Allergy

Status

Published

Research group

  • Chronic Inflammatory and Degenerative Diseases Research Unit
  • Diabetes - Immunovirology
  • Preventive Paediatrics

ISBN/ISSN/Other

  • ISSN: 1465-9921